These results underscore the role of STAT3 in macrophage-driven inflammation and its contribution to tubular epithelial cell injury in L-AKI, further supporting the potential of STAT3 inhibition as a therapeutic strategy. The gene discussed is STAT3; the disease is acute kidney injury.